Lead-binding proteins: A review

Journal of Toxicology

Volumn 2011, Issue , 2011, Pages

  Gonick, Harvey C ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAZEPAM BINDING INHIBITOR; LEAD; METALLOTHIONEIN; PORPHOBILINOGEN SYNTHASE; PORPHOBILINOGEN SYNTHASE 2; THYMOSIN BETA4; UNCLASSIFIED DRUG;

BRAIN; CYTOPLASM; ENVIRONMENTAL EXPOSURE; ERYTHROCYTE; HUMAN; KIDNEY; LIVER; METAL BINDING; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; REVIEW;

ANIMALIA;

EID: 81555227906     PISSN: 16878191     EISSN: 16878205     Source Type: Journal    
DOI: 10.1155/2011/686050     Document Type: Review

References (79)

1. Blackman S. S. Jr, Intranuclear inclusion bodies in the kidney and liver caused by lead poisoning Bulletin of the Johns Hopkins Hospital 1936 58 384 402
2. Shelton K. R., Egle P. M., The proteins of lead-induced intranuclear inclusion bodies Journal of Biological Chemistry 1982 257 19 11802 11807 (Pubitemid 13218647)
3. Egle P. M., Shelton K. R., Chronic lead intoxication causes a brain-specific nuclear protein to accumulate in the nuclei of cells lining kidney tubules Journal of Biological Chemistry 1986 261 5 2294 2298 (Pubitemid 17205162)
4. Shelton K. R., Cunningham J. G., Klann E., Merchant R. E., Egle P. M., Bigbee J. W., Low-abundance 32-kilodalton nuclear protein specifically enriched in the central nervous system Journal of Neuroscience Research 1990 25 3 287 294 (Pubitemid 20136577)
5. Shelton K. R., Egle P. M., Bigbee J. W., Klann E., A nuclear matrix protein stabilized by lead exposure: current knowledge and future prospects NeuroToxicology 1993 14 2-3 61 68 (Pubitemid 23292791)
6. Klann E., Shelton K. R., The effect of lead on the metabolism of a nuclear matrix protein which becomes prominent in lead-induced intranuclear inclusion bodies Journal of Biological Chemistry 1989 264 29 16969 16972 (Pubitemid 19255521)
7. Klann E., Shelton K. R., A lead-associated nuclear protein which increases in maturing brain and in differentiating neuroblastoma 2A cells exposed to cyclic AMP-elevating agents Developmental Brain Research 1990 57 1 71 75
8. Goyer R. A., The renal tubule in lead poisoning. I. Mitochondrial swelling and aminoacidura Laboratory Investigation 1968 19 1 71 77
9. Goyer R. A., Krall A., Kimball J. P., The renal tubule in lead poisoning. II. In vitro studies of mitochondrial structure and function Laboratory Investigation 1968 19 1 78 83
10. Goyer R. A., Leonard D. L., Moore J. F., Rhyne B., Krigman M. R., Lead dosage and the role of the intranuclear inclusion body. An experimental study Archives of Environmental Health 1970 20 6 705 711
11. Goyer R. A., May P., Cates M. M., Krigman M. R., Lead and protein content of isolated intranuclear inclusion bodies from kidneys of lead-poisoned rats Laboratory Investigation 1970 22 3 245 251
12. Choie D. D., Richter G. W., Lead poisoning: rapid formation of intranuclear inclusions Science 1972 177 4055 1194 1195
13. McLachlin J. R., Goyer R. A., Cherian M. G., Formation of lead-induced inclusion bodies in primary rat kidney epithelial cell cultures: effect of actinomycin D and cycloheximide Toxicology and Applied Pharmacology 1980 56 3 418 431 (Pubitemid 11212727)
14. Goyer R. A., Rhyne B. C., Pathological effects of lead International Review of Experimental Pathology 1973 12 1 77
15. Moore J. F., Goyer R. A., Wilson M., Lead-induced inclusion bodies. Solubility, amino acid content, and relationship to residual acidic nuclear proteins Laboratory Investigation 1973 29 5 488 494
16. Moore J. F., Goyer R. A., Lead induced inclusion bodies: composition and probable role in lead metabolism Environmental Health Perspectives 1974 7 121 127
17. Goyer R. A., Cherian M. G., Delaquerriere-Richardson L., Renal effects of repeated administration of calcium disodium ethylenediaminetetraacetate during excessive exposure to lead in rats Journal of Environmental Pathology and Toxicology 1978 1 4 403 410 (Pubitemid 9245637)
18. Choie D. D., Richter G. W., Young L. B., Biogenesis of intranuclear lead protein inclusions in mouse kidney Beitrage zur Pathologie 1975 155 2 197 203
19. Selvn-Testa A., Lopez-Costa J. J., Nessi de Avion A. C., Pecci Saavedra J., Astroglial alterations in rat hippocampus during chronic lead exposure Glia 1991 4 4 384 392
20. Harry G. J., Schmitt T. J., Gong Z., Brown H., Zawia N., Evans H. L., Lead-induced alterations of glial fibrillary acidic protein (GFAP) in the developing rat brain Toxicology and Applied Pharmacology 1996 139 1 84 93 (Pubitemid 26247064)
21. Oskarsson A., Fowler B. A., Effects of lead on the heme biosynthetic pathway in rat kidney Experimental and Molecular Pathology 1985 43 3 409 417 (Pubitemid 16174999)
22. Oskarsson A., Squibb K. S., Fowler B. A., Intracellular binding of lead in the kidney: the partial isolation and characterization of postmitochondrial lead binding components Biochemical and Biophysical Research Communications 1982 104 1 290 298
23. Mistry P., Lucier G. W., Fowler B. A., High-affinity lead binding proteins in rat kidney cytosol mediate cell-free nuclear translocation of lead Journal of Pharmacology and Experimental Therapeutics 1985 232 2 462 469 (Pubitemid 15162907)
24. Goering P. L., Fowler B. A., Regulation of lead inhibition of δ-aminolevulinic acid dehydratase by a low molecular weight, high affinity renal lead-binding protein Journal of Pharmacology and Experimental Therapeutics 1984 231 1 66 71 (Pubitemid 14023113)
25. Goering P. L., Fowler B. A., Mechanism of renal lead-binding protein reversal of δ-aminolevulinic acid dehydratase inhibition by lead Journal of Pharmacology and Experimental Therapeutics 1985 234 2 365 371 (Pubitemid 15241854)
26. Mistry P., Mastri C., Fowler B. A., Influence of metal ions on renal cytosolic lead-binding proteins and nuclear uptake of lead in the kidney Biochemical Pharmacology 1986 35 4 711 713 (Pubitemid 16049190)
27. Mahaffey K. R., Capar S. G., Gladen B. C., Fowler B. A., Concurrent exposure to lead, cadmium, and arsenic. Effects on toxicity and tissue metal concentrations in the rat Journal of Laboratory and Clinical Medicine 1981 98 4 463 481 (Pubitemid 11018717)
28. Mahaffey K. R., Fowler B. A., Effects of concurrent administration of lead, cadmium, and arsenic in the rat Environmental Health Perspectives 1977 19 165 171 (Pubitemid 8182694)
29. Fowler B. A., DuVal G., Effects of lead on the kidney: roles of high-affinity lead-binding proteins Environmental Health Perspectives 1991 91 77 80
30. Smith D. R., Kahng M. W., Quintanilla-Vega B., Fowler B. A., High-affinity renal lead-binding proteins in environmentally-exposed humans Chemico-Biological Interactions 1998 115 1 39 52 (Pubitemid 28375747)
31. Goering P. L., Mistry P., Fowler B. A., A low molecular weight lead-binding protein in brain attenuates lead inhibition of δ- aminolevulinic acid dehydratase: comparison with a renal lead-binding protein Journal of Pharmacology and Experimental Therapeutics 1986 237 1 220 225 (Pubitemid 16116367)
32. DuVal G., Fowler B. A., Preliminary purification and characterization studies of a low molecular weight, high affinity cytosolic lead-binding protein in rat brain Biochemical and Biophysical Research Communications 1989 159 1 177 184 (Pubitemid 19087629)
33. Fowler B. A., Kahng M. W., Smith D. R., Conner E. A., Laughlin N. K., Implications of lead binding proteins for risk assessment of lead exposure Journal of Exposure Analysis and Environmental Epidemiology 1993 3 4 441 448
34. Quintanilla-Vega B., Smith D. R., Kahng M. W., Hernandez J. M., Albores A., Fowler B. A., Lead-binding proteins in brain tissue of environmentally lead-exposed humans Chemico-Biological Interactions 1995 98 3 193 209 (Pubitemid 26027064)
35. Qian Y., Harris E. D., Zheng Y., Tiffany-Castiglioni E., Lead targets GRP78, a molecular chaperone, in C6 rat glioma cells Toxicology and Applied Pharmacology 2000 163 3 260 266 (Pubitemid 30158555)
36. Qian Y., Zheng Y., Ramos K. S., Tiffany-Castiglioni E., GRP78 compartmentalized redistribution in Pb-treated glia: role of GRP78 in lead-induced oxidative stress NeuroToxicology 2005 26 2 267 275 (Pubitemid 40248444)
37. Qian Y., Zheng Y., Ramos K. S., Tiffany-Castiglioni E., The involvement of copper transporter in lead-induced oxidative stress in astroglia Neurochemical Research 2005 30 4 429 438 (Pubitemid 40933650)
38. Barltrop D., Smith A., Lead binding to human haemoglobin Experientia 1972 28 1 76 77
39. Lolin Y., O'Gorman P., An intra-erythrocytic low molecular weight lead-binding protein in acute and chronic lead exposure and its possible protective role in lead toxicity Annals of Clinical Biochemistry 1988 25 6 688 697
40. Ong C. N., Lee W. R., Distribution of lead-203 in human peripheral blood in vitro British Journal of Industrial Medicine 1980 37 1 78 84 (Pubitemid 10095696)
41. Raghavan S. R. V., Gonick H. C., Isolation of low-molecular-weight lead-binding protein from human erythrocytes Proceedings of the Society for Experimental Biology and Medicine 1977 155 2 164 167 (Pubitemid 8139772)
42. Warren M. J., Cooper J. B., Wood S. P., Shoolingin-Jordan P. M., Lead poisoning, haem synthesis and 5-aminolaevulinic acid dehydratase Trends in Biochemical Sciences 1998 23 6 217 221 (Pubitemid 28302619)
43. Raghavan S. R. V., Culver B. D., Gonick H. C., Erythrocyte lead-binding protein after occupational exposure. I. Relationship to lead toxicity Environmental Research 1980 22 1 264 270 (Pubitemid 11217997)
44. Raghavan S. R. V., Culver B. D., Gonick H. C., Erythrocyte lead-binding protein after occupational exposure. II. Influence on lead inhibition of membrane Na+,K+-adenosinetriphosphatase Journal of Toxicology and Environmental Health 1981 7 3-4 561 568 (Pubitemid 11104557)
45. Gonick H. C., Khalil-Manesh F., Raghavan S. R. V., Lekkas T. D., Characterization of human erythrocyte lead-binding protein International Conference: Heavy Metals in the Environment. Athens, Greece 1985 1 Edinburgh, UK CEP consultants 313 316
46. Church H. J., Day J. P., Braithwaite R. A., Brown S. S., The speciation of lead in erythrocytes in relation to lead toxicity: case studies of two lead-exposed workers NeuroToxicology 1993 14 2-3 359 364 (Pubitemid 23292820)
47. Church H. J., Day J. P., Braithwaite R. A., Brown S. S., Binding of lead to a metallothionein-like protein in human erythrocytes Journal of Inorganic Biochemistry 1993 49 1 55 68
48. Xie Y., Chiba M., Shinohara A., Watanabe H., Inaba Y., Studies on lead-binding protein and interaction between lead and selenium in the human erythrocytes Industrial Health 1998 36 3 234 239 (Pubitemid 28354765)
49. Buchet J. P., Roels H., Hubermont G., Lauwerys R., Effect of lead on some parameters of the heme biosynthetic pathway in rat tissues in vivo Toxicology 1976 6 1 21 34
50. Granick J. L., Sassa S., Granick S., Levere R. D., Kappas A., Studies in lead poisoning. II. Correlation between the ratio of activated to inactivated δ-aminolevulinic acid dehydratase of whole blood and the blood lead level Biochemical Medicine 1973 8 1 149 159
51. Boudene C., Despaux-Pages N., Comoy E., Bohuon C., Immunological and enzymatic studies of erythrocytic -aminolevulinate dehydratase. Comparison of results obtained in normal and lead-exposured subjects International Archives of Occupational and Environmental Health 1984 55 1 87 96 (Pubitemid 15177858)
52. Fujita H., Sato K., Sano S., Increase in the amount of erythrocyte δ-aminolevulinic acid dehydratase in workers with moderate lead exposure International Archives of Occupational and Environmental Health 1982 50 3 287 297 (Pubitemid 12053118)
53. Fujita H., Orii Y., Sano S., Evidence of increased synthesis of δ-aminolevulinic acid dehydratase in experimental lead-poisoned rats Biochimica et Biophysica Acta 1981 678 1 39 50 (Pubitemid 12218946)
54. Astrin K. H., Bishop D. F., Wetmur J. G., Kaul B., Davidow B., Desnick R. J., δ-aminolevulinic acid dehydratase isozymes and lead toxicity Annals of the New York Academy of Sciences 1987 514 23 29
55. Bergdahl I. A., Grubb A., Schtz A., Desnick R. J., Wetmur J. G., Sassa S., Skerfving S., Lead binding to δ-aminolevulinic acid dehydratase (ALAD) in human erythrocytes Pharmacology and Toxicology 1997 81 4 153 158 (Pubitemid 27432568)
56. Kim H. S., Lee S. S., Lee G. S., Hwangbo Y., Ahn K. D., Lee B. K., The protective effect of δ-aminolevulinic acid dehydratase 1-2 and 2-2 isozymes against blood lead with higher hematologic parameters Environmental Health Perspectives 2004 112 5 538 541 (Pubitemid 38500040)
57. Pérez-Bravo F., Ruz M., Morn-Jiménez M. J., Olivares M., Rebolledo A., Codoceo J., Seplveda V., Jenkin A., Santos J. L., Fontanellas A., Association between aminolevulinate dehydrase genotypes and blood lead levels in children from a lead-contaminated area in Antofagasta, Chile Archives of Environmental Contamination and Toxicology 2004 47 2 276 280 (Pubitemid 38963054)
58. Smith C. M., Wang X., Hu H., Kelsey K. T., A polymorphism in the δ-aminolevulinic acid dehydratase gene may modify the pharmacokinetics and toxicity of lead Environmental Health Perspectives 1995 103 3 248 253
59. Wetmur J. G., Lehnert G., Desnick R. J., The -aminolevulinate dehydratase polymorphism: higher blood lead levels in lead workers and environmentally exposed children with the 1-2 and 2-2 isozymes Environmental Research 1991 56 2 109 119
60. Wetmur J. G., Influence of the common human -aminolevulinate dehydratase polymorphism on lead body burden Environmental Health Perspectives 1994 102 supplement 3 215 219 (Pubitemid 24316385)
61. Kelada S. N., Shelton E., Kaufmann R. B., Khoury M. J., δ-aminolevulinic acid dehydratase genotype and lead toxicity: a HuGE review American Journal of Epidemiology 2001 154 1 1 13 (Pubitemid 32565680)
62. Wetmur J. G., Kaya A. H., Plewinska M., Desnick R. J., Molecular characterization of the human -aminolevulinate dehydratase 2 (ALAD2) allele: implications for molecular screening of individuals for genetic susceptibility to lead poisoning American Journal of Human Genetics 1991 49 4 757 763 (Pubitemid 21891722)
63. Sithisarankul P., Schwartz B. S., Lee B. K., Kelsey K. T., Strickland P. T., Aminolevulinic acid dehydratase genotype mediates plasma levels of the neurotoxin, 5-aminolevulinic acid, in lead-exposed workers American Journal of Industrial Medicine 1997 32 1 15 20 (Pubitemid 27203507)
64. Schwartz B. S., Lee B. K., Stewart W., Ahn K. D., Kelsey K., Bressler J., Associations of subtypes of hemoglobin with -acid dehydratase genotype and dimercaptosuccinic acid-chelatable lead levels Archives of Environmental Health 1997 52 2 97 103 (Pubitemid 27150453)
65. Bergdahl I. A., Sheveleva M., Schutz A., Artamonova V. G., Skerfving S., Plasma and blood lead in humans: capacity-limited binding to δ-aminolevulinic acid dehydratase and other lead-binding components Toxicological Sciences 1998 46 2 247 253 (Pubitemid 29069608)
66. Goering P. L., Fowler B. A., Kidney zinc-thionein regulation of δ-aminolevulinic acid dehydratase inhibition by lead Archives of Biochemistry and Biophysics 1987 253 1 48 55 (Pubitemid 17025212)
67. Sabbioni E., Marafante E., Identification of lead binding components in rat liver: in vivo study Chemico-Biological Interactions 1976 15 1 1 20
68. Fullmer C. S., Edelstein S., Wasserman R. H., Lead-binding properties of intestinal calcium-binding proteins Journal of Biological Chemistry 1985 260 11 6816 6819 (Pubitemid 15010609)
69. Singh J., Pritchard D. E., Carlisle D. L., McLean J. A., Montaser A., Orenstein J. M., Patierno S. R., Internalization of carcinogenic lead chromate particles by cultured normal human lung epithelial cells: formation of intracellular lead-inclusion bodies and induction of apoptosis Toxicology and Applied Pharmacology 1999 161 3 240 248 (Pubitemid 30041796)
70. Maitani T, Watahiki A., Suzuki K. T., Induction of metallothionein after lead administration by three injection routes in mice Toxicology and Applied Pharmacology 1986 83 2 211 217 (Pubitemid 16079406)
71. Ikebuchi H., Teshima R., Suzuki K., Simultaneous induction of Pb-metallothionein-like protein and Zn-thionein in the liver of rats given lead acetate Biochemical Journal 1986 233 2 541 546 (Pubitemid 16169505)
72. Goering P. L., Fowler B. A., Regulatory roles of high-affinity metal-binding proteins in mediating lead effects on δ-aminolevulinic acid dehydratase Annals of the New York Academy of Sciences 1987 514 235 247 (Pubitemid 18097974)
73. Liu J., Kershaw W. C., Klaassen C. D., The protective effect of metallothionein on the toxicity of various metals in rat primary hepatocyte culture Toxicology and Applied Pharmacology 1991 107 1 27 34
74. Qu W., Diwan B. A., Liu J., Goyer R. A., Dawson T., Horton J. L., Cherian M. G., Waalkes M. P., The metallothionein-null phenotype is associated with heightened sensitivity to lead toxicity and an inability to form inclusion bodies American Journal of Pathology 2002 160 3 1047 1056 (Pubitemid 34228875)
75. Waalkes M. P., Liu J., Goyer R. A., Diwan B. A., Metallothionein-I/II double knockout mice are hypersensitive to lead-induced kidney carcinogenesis: role of inclusion body formation Cancer Research 2004 64 21 7766 7772 (Pubitemid 39446908)
76. Zuo P., Qu W., Cooper R. N., Goyer R. A., Diwan B. A., Waalkes M. P., Potential role of -synuclein and metallothionein in lead-induced inclusion body formation Toxicological Sciences 2009 111 1 100 108
77. Kirberger M., Yang J. J., Structural differences between Pb 2+ - and Ca 2+ -binding sites in proteins: implications with respect to toxicity Journal of Inorganic Biochemistry 2008 102 10 1901 1909
78. Hanas J. S., Rodgers J. S., Bantle J. A., Cheng Y. G., Lead inhibition of DNA-binding mechanism of Cys 2 His 2 zinc finger proteins Molecular Pharmacology 1999 56 5 982 988
79. Becker J. S., Mounicou S., Zoriy M. V., Becker J. S., Lobinski R., Analysis of metal-binding proteins separated by non-denaturating gel electrophoresis using matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) and laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS) Talanta 2008 76 5 1183 1188